MKP: Explanation for business result in QII-2011
Mekophar Chemical Pharmaceutical JSC (HOSE: MKP) explained the 13.8 percent increase in profit after tax of QII-2011 compared to QII-2010:
Although material prices and other expenses have increased, the Company tried to raised revenue of QII-2011 by 26.7% compared to QII-2010, mainly thanks to:
- Revenue from finished product: Up 12%
- Revenue from goods: Up 15%
- Revenue from materials and services: Up 0.3%
Besides, the Company also saved expenses in business operations, so that made profit in QII-2011 increase.
HOSE
> GTA: Explanation for increase of profit in QII-2011 (08/08/2011)
> SBA: Explanation for business result in QII-2011 (06/08/2011)
> PHR: BOD Resolution No.4 (06/08/2011)
> BSI: Resolution of Extraordinary Shareholders’ Meeting 2011 (06/08/2011)
> DCL: Late submission of FS report & annual report (Time 3rd) (06/08/2011)
> PXS: The BOD’s resolution (08/08/2011)
> DIC: Explanation for business result in QII-2011 (06/08/2011)
> SDT: Board Resolution (04/08/2011)
> BT6: QII-2011 Financial Statements submission extension (04/08/2011)
> DRH: Explanation for business result in quarter 2.2011 (04/08/2011)